Livalo Generic Name & Formulations
Adjunct to diet to reduce LDL-C: in adults with primary hyperlipidemia; or in adults and children with heterozygous familial hypercholesterolemia (HeFH).
Livalo Dosage and Administration
Adults and Children
<8yrs: not established. ≥8yrs: Initially 2mg once daily; may increase after 4 weeks to max 4mg once daily. If patient requires a high-intensity statin or is unable to achieve the LDL-C goal with 4mg daily, prescribe alternative LDL-C-lowering treatment. Moderate to severe renal impairment (eGFR <60mL/min/1.73m2, or ESRD with hemodialysis): 1mg once daily; max 2mg once daily. Concomitant erythromycin: max 1mg once daily. Concomitant rifampin: max 2mg once daily.
Concomitant cyclosporine. Acute liver failure or decompensated cirrhosis.
Livalo Boxed Warnings
Discontinue if myopathy or markedly elevated CK levels occur; suspend if a predisposition to development of renal failure secondary to rhabdomyolysis develops. Risk factors for myopathy (eg, renal impairment, uncontrolled hypothyroidism, age ≥65yrs, concomitant certain drugs including other lipid-lowering therapies). Immune-mediated necrotizing myopathy; discontinue if suspected. Monitor liver function prior to initiation and repeat as clinically indicated. Discontinue if serious liver injury with clinical symptoms and/or hyperbilirubinemia or jaundice occurs. Substantial alcohol ingestion. Advise females of reproductive potential to use effective contraception during treatment. Pregnancy: discontinue when recognized. Nursing mothers: not recommended.
Fecal (79%), renal (15%). Half-life: ~12 hours.
Livalo Adverse Reactions
Livalo Clinical Trials
Livalo Patient Counseling